Functional Medicine Approaches to Neurodegeneration

Alzheimer's disease facts and figures [published online ahead of print, 2020 Mar 10].

Alzheimers Dement. https://doi.org/10.1002/alz.12068Hou Y. Dan X. Babbar M. et al.

Ageing as a risk factor for neurodegenerative disease.

Nat Rev Neurol. 15: 565-581

Effects of Alzheimer Disease on Patients and Their Family.

J Nucl Med Technol. 46: 335-340

Pathology of Neurodegenerative Diseases.

Cold Spring Harb Perspect Biol. 9a028035Liu P.P. Xie Y. Meng X.Y. et al.

History and progress of hypotheses and clinical trials for Alzheimer's disease.

Signal Transduct Target Ther. : 37https://doi.org/10.1038/s41392-019-0063-8Hampel H. Caraci F. Cuello A.C. et al.

A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease.

Front Immunol. 11: 456https://doi.org/10.3389/fimmu.2020.00456Fotuhi M. Lubinski B. Trullinger M. et al.

A Personalized 12-week "Brain Fitness Program" for Improving Cognitive Function and Increasing the Volume of Hippocampus in Elderly with Mild Cognitive Impairment.

J Prev Alzheimers Dis. 3: 133-137

Reversal of cognitive decline: a novel therapeutic program.

Aging (Albany NY). 6: 707-717Schneider J. Joen D. Gladman J. et al.

The Alzheimer’s disease-releated dementias summit.

National Institute of Neurological Disorders and Stroke. Lane C.A. Hardy J. Schott J.M.

Alzheimer's disease.

Eur J Neurol. 25: 59-70Sweeney M.D. Sagare A.P. Zlokovic B.V.

Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.

Nat Rev Neurol. 14: 133-150

Astrocytes in neurodegenerative disease.

Cold Spring Harb Perspect Biol. 7a020628

Microglia-Mediated Inflammation and Neurodegenerative Disease.

Mol Neurobiol. 53: 6709-6715Golpich M. Amini E. Mohamed Z. et al.

Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment.

CNS Neurosci Ther. 23: 5-22Ghaisas S. Maher J. Kanthasamy A.

Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases.

Pharmacol Ther. 158: 52-62Colucci-D'Amato L. Speranza L. Volpicelli F.

Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer.

Int J Mol Sci. 21: 7777Ciccocioppo F. Bologna G. Ercolino E. et al.

Neurodegenerative diseases as proteinopathies-driven immune disorders.

Neural Regen Res. 15: 850-856

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.

Nature. 443: 787-795

Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling.

Mitochondrion. 49: 35-45https://doi.org/10.1016/j.mito.2019.07.003

Brain energetics, mitochondria, and traumatic brain injury.

Rev Neurosci. 31: 363-390Akbari M. Kirkwood T.B.L. Bohr V.A.

Mitochondria in the signaling pathways that control longevity and health span.

Ageing Res Rev. 54: 100940https://doi.org/10.1016/j.arr.2019.100940Raefsky S.M. Mattson M.P.

Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance.

Free Radic Biol Med. 102: 203-216https://doi.org/10.1016/j.freeradbiomed.2016.11.045Memme J.M. Erlich A.T. Phukan G. et al.

Exercise and mitochondrial health.

J Physiol. 599: 803-817Valenzuela M.J. Matthews F.E. Brayne C. et al.

Multiple biological pathways link cognitive lifestyle to protection from dementia.

Biol Psychiatry. 71: 783-791Gaignard P. Liere P. Thérond P. et al.

Role of Sex Hormones on Brain Mitochondrial Function, with Special Reference to Aging and Neurodegenerative Diseases.

Front Aging Neurosci. 9: 406https://doi.org/10.3389/fnagi.2017.00406Chodari L. Dilsiz Aytemir M. Vahedi P. et al.

Targeting Mitochondrial Biogenesis with Polyphenol Compounds.

Oxid Med Cell Longev. 2021: 4946711https://doi.org/10.1155/2021/4946711Potì F. Santi D. Spaggiari G. et al.

Polyphenol Health Effects on Cardiovascular and Neurodegenerative Disorders: A Review and Meta-Analysis.

Int J Mol Sci. 20: 351von Bernhardi R. Eugenín J.

Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms.

Antioxid Redox Signal. 16: 974-1031Wadhwa R. Gupta R. Maurya P.K.

Oxidative Stress and Accelerated Aging in Neurodegenerative and Neuropsychiatric Disorder.

Curr Pharm Des. 24: 4711-4725Ullah A. Munir S. Badshah S.L. et al.

Important Flavonoids and Their Role as a Therapeutic Agent.

Molecules. 25: 5243Jiang Q. Yin J. Chen J. et al.

Mitochondria-Targeted Antioxidants: A Step towards Disease Treatment.

Oxid Med Cell Longev. 2020: 8837893https://doi.org/10.1155/2020/8837893Pahrudin Arrozi A. Wan Ngah W.Z. Mohd Yusof Y.A. et al.

Antioxidant modulation in restoring mitochondrial function in neurodegeneration.

Int J Neurosci. 127: 218-235Siddiqui A.N. Siddiqui N. Khan R.A. et al.

Neuroprotective Role of Steroidal Sex Hormones: An Overview.

CNS Neurosci Ther. 22: 342-350Pugazhenthi S. Qin L. Reddy P.H.

Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.

Biochim Biophys Acta Mol Basis Dis. 1863: 1037-1045Pasinetti G.M. Zhao Z. Qin W. et al.

Caloric intake and Alzheimer's disease. Experimental approaches and therapeutic implications.

Interdiscip Top Gerontol. 35: 159-175https://doi.org/10.1159/000096561Wang J. Ho L. Qin W. et al.

Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease.

FASEB J. 19: 659-661Bagherniya M. Butler A.E. Barreto G.E. et al.

The effect of fasting or calorie restriction on autophagy induction: A review of the literature.

Ageing Res Rev. 47: 183-197https://doi.org/10.1016/j.arr.2018.08.004Baik S.H. Rajeev V. Fann D.Y. et al.

Intermittent fasting increases adult hippocampal neurogenesis.

Brain Behav. 10: e01444Musiek E.S. Holtzman D.M.

Mechanisms linking circadian clocks, sleep, and neurodegeneration.

Science. 354: 1004-1008Bonaconsa M. Colavito V. Pifferi F. et al.

Cell clocks and neuronal networks: neuron ticking and synchronization in aging and aging-related neurodegenerative disease.

Curr Alzheimer Res. 10: 597-608

Therapeutic implications of circadian clocks in neurodegenerative diseases.

J Neurosci Res. 98: 1095-1113

Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration.

J Physiol. 595: 489-503Rutsch A. Kantsjö J.B. Ronchi F.

The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology.

Front Immunol. 11: 604179https://doi.org/10.3389/fimmu.2020.604179Goyal D. Ali S.A. Singh R.K.

Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.

Prog Neuropsychopharmacol Biol Psychiatry. 106: 110112https://doi.org/10.1016/j.pnpbp.2020.110112Marogianni C. Sokratous M. Dardiotis E. et al.

Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disease.

Int J Mol Sci. 21: 8421

A nutritional approach to microbiota in Parkinson's disease.

Biosci Microbiota Food Health. 38: 115-127Wang Q. Luo Y. Ray Chaudhuri K. et al.

The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.

Brain. 144: 2571-2593

Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches.

Lancet Neurol. 19: 758-766Neumann K.F. Rojo L. Navarrete L.P. et al.

Insulin resistance and Alzheimer's disease: molecular links & clinical implications.

Curr Alzheimer Res. 5: 438-447Liang Y. Xu X. Yin M. et al.

Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis.

Endocr J. 66: 51-63

Molecular mechanisms of proteinopathies across neurodegenerative disease: a review.

Neurol Res Pract. 1: 35https://doi.org/10.1186/s42466-019-0039-8Nichols M.R. St-Pierre M.K. Wendeln A.C. et al.

Inflammatory mechanisms in neurodegeneration.

J Neurochem. 149: 562-581

Microglia in Parkinson's Disease.

Adv Exp Med Biol. 1175: 335-353Glass C.K. Saijo K. Winner B. et al.

Mechanisms underlying inflammation in neurodegeneration.

Cell. 140: 918-934Ray R. Juranek J.K. Rai V.

RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis.

Neurosci Biobehav Rev. 62: 48-55Stolp H.B. Dziegielewska K.M.

Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.

Neuropathol Appl Neurobiol. 35: 132-146Calderón-Garcidueñas L. Leray E. Heydarpour P. et al.

Air pollution, a rising environmental risk factor for cognition, neuroinflammation and neurodegeneration: The clinical impact on children and beyond.

Rev Neurol (Paris). 172: 69-80McGrattan A.M. McGuinness B. McKinley M.C. et al.

Diet and Inflammation in Cognitive Ageing and Alzheimer's Disease.

Curr Nutr Rep. 8: 53-65Więckowska-Gacek A. Mietelska-Porowska A. Wydrych M. et al.

Western diet as a trigger of Alzheimer's disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration.

Ageing Res Rev. 70: 101397https://doi.org/10.1016/j.arr.2021.101397Rakic S. Hung Y.M.A. Smith M. et al.

Systemic infection modifies the neuroinflammatory response in late stage Alzheimer's disease.

Acta Neuropathol Commun. 6: 88Pennisi M. Crupi R. Di Paola R. et al.

Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer disease.

J Neurosci Res. 95: 1360-1372Canhada S. Castro K. Perry I.S. et al.

Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review.

Nutr Neurosci. 21: 529-538Calis Z. Mogulkoc R. Baltaci A.K.

The Roles of Flavonols/Flavonoids in Neurodegeneration and Neuroinflammation.

Mini Rev Med Chem. 20: 1475-1488Guo L.T. Wang S.Q. Su J. et al.

Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K/AKT/FoxO1 pathway.

J Neuroinflammation. 16: 95Yang G. Wang Y. Tian J. et al.

Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials.

PLoS One. 8e74916Liao Z. Cheng L. Li X. et al.

Meta-analysis of Ginkgo biloba Preparation for the Treatment of Alzheimer's Disease.

Clin Neuropharmacol. 43: 93-99

留言 (0)

沒有登入
gif